XENE Xenon Pharmaceuticals Inc.

8.76
+0.02  (+0%)
Previous Close 8.74
Open 8.8
Price To Book -1.18
Market Cap 225,789,491
Shares 25,775,056
Volume 43,608
Short Ratio
Av. Daily Volume 62,797

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data due 2H 2020.
XEN1101
Adult focal seizures
Phase 2 data released March 24, 2017 - endpoints not met.
XEN801
Acne
Phase 2b data released June 27, 2017. Endpoints not met.
TV-45070
Postherpetic neuralgia
Phase 2b trial did not meet endpoints - July 2015
TV-45070
Osteoarthritis
Phase 2 trial to be initiated 2019.
XEN901
Pediatric epilepsy
Phase 3 trial to be initiated following IND filing 4Q 2019.
XEN496
Epilepsy

Latest News

  1. Is Xenon Pharmaceuticals (NASDAQ:XENE) Using Too Much Debt?
  2. Edited Transcript of XENE earnings conference call or presentation 6-Aug-19 8:30pm GMT
  3. Xenon Pharmaceuticals Inc. (XENE) Q2 2019 Earnings Call Transcript
  4. Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update
  5. Do Institutions Own Shares In Xenon Pharmaceuticals Inc. (NASDAQ:XENE)?
  6. Hedge Funds Have Never Been This Bullish On Xenon Pharmaceuticals Inc (XENE)
  7. Xenon Pharmaceuticals Presents Corporate Update on Neurology-Focused Pipeline at the Jefferies 2019 Healthcare Conference
  8. Edited Transcript of XENE earnings conference call or presentation 7-May-19 8:30pm GMT
  9. Xenon Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
  10. Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Overpaying Its CEO?
  11. Xenon Pharmaceuticals: 1Q Earnings Snapshot
  12. Xenon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
  13. Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results and Provide Corporate Update
  14. Xenon Pharmaceuticals to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
  15. Xenon Pharmaceuticals Inc. (NASDAQ:XENE): Immense Growth Potential?
  16. Edited Transcript of XENE earnings conference call or presentation 6-Mar-19 9:30pm GMT
  17. Xenon Pharmaceuticals Reports 2018 Financial Results and Provides Corporate Update
  18. Xenon Pharmaceuticals Inc. to Host Earnings Call
  19. The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split